In an op-ed in STAT News, Regine Sitruk-Ware, Distinguished Scientist at Population Council, highlights the latest advancements in male contraceptive research and dispels common misconceptions about the future of male birth control.
Several promising male contraceptive products are currently making their way through clinical trials, Vox writes, including Nestorone®/Testosterone transdermal gel, a new topical gel that blocks sperm production.
During the UN Commission on the Status of Women (CSW), new Population Council insights about the power of research to understand, measure, and encourage abandonment of female genital mutilation/cutting (FGM/C) were highlighted through high-level events and press coverage.
*This op-ed was orinially published in the Feb. 6th print edition of The Daily Nation, the Kenyan newspaper.
There are many things we know – with certainty – about female genital mutilation/cutting (FGM/C). We know that more than 200 million women and girls in the world have undergone FGM/C. We know that it happens in parts of Kenya – and that it is against the law in this country. While the evidence of FGM/C’s physical and mental harms is well-documented, we know there are people who support it as a cultural practice. We also know that many people are against it: people who see an obligation to respect the human rights of girls and women.
While girls’ leadership is needed in the fight against climate change, researchers are recognizing the varied ways that natural disasters threaten gains in girls’ education and wellbeing around the world, write Population Council experts in a Brookings Institution blog, which also appears on Inter Press Service and ReliefWeb.